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Abstract
Hypothalamic neurons are main regulators of energy homeostasis. Neuronal function essentially depends on plasma
membrane-located gangliosides. The present work demonstrates that hypothalamic integration of metabolic signals
requires neuronal expression of glucosylceramide synthase (GCS; UDP-glucose:ceramide glucosyltransferase). As a major
mechanism of central nervous system (CNS) metabolic control, we demonstrate that GCS-derived gangliosides interacting
with leptin receptors (ObR) in the neuronal membrane modulate leptin-stimulated formation of signaling metabolites in
hypothalamic neurons. Furthermore, ganglioside-depleted hypothalamic neurons fail to adapt their activity (c-Fos) in
response to alterations in peripheral energy signals. Consequently, mice with inducible forebrain neuron-specific deletion of
the UDP-glucose:ceramide glucosyltransferase gene (Ugcg) display obesity, hypothermia, and lower sympathetic activity.
Recombinant adeno-associated virus (rAAV)-mediated Ugcg delivery to the arcuate nucleus (Arc) significantly ameliorated
obesity, specifying gangliosides as seminal components for hypothalamic regulation of body energy homeostasis.
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Introduction
The investigation of pathogenetic mechanisms underlying
obesity has attained significant interest, as obesity has become
an endemic metabolic disturbance worldwide. Elevated peripheral
energy storage can develop as a consequence of alterations in the
neuronal feedback circuits regulating energy homeostasis. The
hypothalamus is the main CNS integrator of peripheral energy
signals, matching energy intake to energy expenditure for body
weight maintenance [1].
Among the most extensively studied peripheral molecules
involved in regulating energy homeostasis and feeding behavior
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in the CNS are the adipocyte-derived hormone leptin as well as
insulin [2,3]. Among numerous leptin- and insulin-sensitive brain
areas, the hypothalamic Arc is one of the main regions integrating
peripheral energy signals and initiating adaptive metabolic and
behavioral responses [4].
Recently, several CNS regions targeted by leptin have emerged
that are involved in the regulation of energy metabolism, such as
the brain stem nucleus of the solitary tract (NTS) and reward
circuits involving the ventral tegmental area [5,6]. Still, leptin is
suggested to exert anti-obesity effects by signaling through ‘‘long
form’’ leptin receptors (ObR) abundantly present on both
orexigenic neuropeptide Y (NPY)/agouti-related peptide (AgRP)
neurons and anorexigenic pro-opiomelanocortin (POMC) neurons
in the Arc. Excess NPY signaling abates sympathetically mediated
thermogenesis, thereby reducing energy expenditure [7]. NPY and
AgRP expression is attenuated upon ObR-induced phosphatidy-
linositol-3-OH-kinase (PI3k) signaling [8]. Conversely, leptin
stimulates the expression of the POMC-derived neurotransmitter
a-melanocyte-stimulating hormone (a-MSH) through the Janus
kinase/signal transducer and activator of transcription (Jak-Stat)
pathway [9]. Alpha-MSH, a potent agonist of melanocortin
receptors, inhibits food intake and stimulates the expenditure of
excess energy in the body, thus preventing obesity development
[10].
Insulin exerts its anorexigenic effects in hypothalamic neurons
by directly stimulating insulin receptor autophosphorylation and
activation of PI3k. Even though both insulin and leptin receptor
stimulation leads to activation of PI3k and subsequent formation
of phosphatidylinositol (3,4,5)-triphosphate (PIP3) [11], it has been
shown that both hormones exert converging direct actions on
POMC neurons, while having opposite effects on AgRP/NPY
neurons [12].
GCS is the key enzyme for the biosynthesis of glycosphingo-
lipids (GSLs) and gangliosides, a class of acidic GSLs abundantly
expressed by neurons and glial cells [13,14]. Ganglioside-depleted
neurons are viable and show apoptosis rates comparable to wild-
type neurons [15]. GSLs including gangliosides contribute to the
formation of membrane microdomains, which are important
mediators of intracellular signal transduction [16]. GCS expres-
sion is crucial for initial postnatal brain maturation and
Ugcgf/f//NesCre mice with constitutive Ugcg deletion in brain tissue
under the control of the nestin promoter die within 3 wk after
birth [15]. In 2003, it was shown that GM3 synthase-deficient
mice are more sensitive to insulin, thereby protecting these mice
from high-fat-diet-induced insulin resistance [17]. A different
ganglioside species, GD1a, has been shown to exert activating
effects on tyrosine kinase receptors [18]. To address the functional
role of GCS in neuronal regulation of energy homeostasis, we have
generated and characterized mice with inducible neuron-specific
Ugcg deletion in adult mouse CNS (Ugcgf/f//CamKCreERT2 mice).
Cre activity in this mouse model was restricted to distinct
populations of forebrain neurons. Hypothalamic nuclei involved
in the regulation of energy homeostasis were targeted by this
approach. Explicitly, Cre activity was absent in the brain stem
NTS, which also contributes to regulation of energy homeostasis.
The present study highlights GCS-derived gangliosides as
mediators for ObR-dependent signal transduction at the hypo-
thalamic neuronal membrane. GCS-depleted neurons failed to
show ObR activation upon leptin stimulation. Major neuronal
gangliosides GM1 and GD1a were recruited to ObR upon ligand
stimulation and subsequent signal transduction depended
on ganglioside expression in hypothalamic neurons.
Ugcgf/f//CamKCreERT2 mice deficient in GSLs in hypothalamus
developed progressive obesity and decreased sympathetically
mediated thermogenesis. rAAV-mediated Ugcg delivery to the
hypothalamic Arc with ensuing nucleus-specific GSL synthesis
significantly ameliorated obesity.
Results
Ganglioside Depletion in Cre-Targeted Neurons in Vivo
and in Vitro
Ugcgflox/flox (Ugcgf/f) mice were bred with mice expressing the
inducible CreERT2 recombinase under the control of the
Calcium/Calmodulin-dependent Kinase II-alpha (CamK) promot-
er, resulting in forebrain neuron-specific Ugcg deletion
(Ugcgf/f//CamKCreERT2) followed by ganglioside depletion after
tamoxifen injection (Figure 1A). Generation of Ugcgf/f mice and
CamKCreERT2 mice has been described earlier [15,19].
Beta-galactosidase (X-Gal) staining of brains from
R26R/Ugcgf/+//CamKCreERT2 reporter mice indicated strong Cre
activity in distinct hypothalamic nuclei, namely in the Arc
(Figures 1B and S1B), in the paraventricular nucleus, and in
median preoptic area (MnPO) (Figure S1A,B). Additional Cre
activity was detected in the lateral hypothalamic area (LHA), in
hippocampus, and in the cerebral cortex (Figure S1A,B). Notably,
Cre activity was absent in the ventromedial hypothalamus and the
NTS in the brain stem (Figure S1A,B). Ganglioside depletion was
confirmed in Cre-targeted areas by GD1a immunofluorescence,
whereas non-targeted areas retained GD1a expression (Figure 1B
and Figure S1A).
Consistent with the expected Cre-activity pattern, in situ
hybridization showed Ugcg mRNA depletion in hippocampus,
cerebral cortex, amygdala, as well as hypothalamic nuclei (Figure
S1C). Recombination events were absent in peripheral organs and
peripheral nervous tissue (Figure S1D).
Neuron-dense total hippocampi showed significant and stable
ganglioside reduction 3 wk postinduction (p.i.), as assessed by thin
layer chromatography (TLC) (Figure S1E). Residual gangliosides
in the dissected tissue were assumed to result from glial cells as well
as from innervating nerve fibers emerging from nontargeted
neurons [14]. Ceramide levels in Cre-targeted neuronal
Author Summary
Obesity is a growing health threat that affects nearly half a
billion people worldwide, and its incidence rates in lower
income countries are rising dramatically. As obesity is a
major risk factor for type II diabetes and cardiovascular
disease, significant effort has been put into the exploration
of causes, prevention, and potential treatment. Recent
research has demonstrated that a region of the brain
called the hypothalamus is a major integrator of metabolic
and nutrient signals, adapting food intake and energy
expenditure to current metabolic needs. Leptin or insulin
receptors located in the plasma cell membrane of neurons
sense energy signals from the body. They transmit this
information inside the cell, which then regulates neuronal
function. In this study, we show that leptin receptors
interact with gangliosides, a class of plasma membrane
lipids. This interaction is a prerequisite for proper receptor
activation. Consequently, ganglioside loss in hypothalamic
neurons inhibits leptin receptor signal transduction in
response to energy metabolites. Furthermore, mice lacking
gangliosides in distinct forebrain areas, amongst them the
hypothalamus, develop progressive obesity and hypother-
mia. Our results suggest a previously unknown regulatory
mechanism of plasma membrane lipids for hypothalamic
control of body weight.
GCS Regulates ObR in Hypothalamic Neurons
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populations were unchanged (Figure 1C), and a slight increase in
sphingomyelin could be detected (Figure S1F).
In order to investigate if ganglioside depletion abated general
neuronal function and integrity in Ugcgf/f//CamKCreERT2 mice, both
electron microscopy and electrophysiological slice recordings were
done at late time points p.i. Electron microscopy from Arc neurons
displayed normal ultrastructure of the neuronal nucleus, organ-
elles, and an intact, regular plasma membrane of
Ugcgf/f//CamKCreERT2 mice both 6 and 12 wk p.i. (Figure 1D).
Basic biophysical parameters [spontaneous firing rate, action
potential (AP) width, and AP rate of rise] from slice recordings of
Arc neurons 12 wk p.i. were unaltered (Figure S2A). The resting
Figure 1. Normal ultrastructure in ganglioside-depleted neurons. (A) Major pathway for biosynthesis of GSL including gangliosides in the
brain. (B) X-Gal staining in brains of R26R/Ugcgf/+//CamKCreERT2 reporter mice revealed strong Cre activity in the hypothalamic Arc. GD1a
immunofluorescence visualized ganglioside depletion in the Arc of Ugcgf/f//CamKCreERT2 mice 6 wk p.i. Scale bar: 75 mm. (C) Ceramide levels were not
significantly altered in hippocampus of Ugcgf/f//CamKCreERT2 mice. Quantification from densitometry analysis of TLC results is depicted (n = 3). (D)
Neurons in the Arc of Ugcgf/f//CamKCreERT2 mice showed normal ultrastructural morphology of plasma membrane (pm), nucleus (N), mitochondria (M),
endoplasmic reticulum (ER), golgi (G), projections (P), and myelin sheaths (my) 6 and 12 wk p.i. Scale bar: 2 mm. 3rdv, third ventricle.
doi:10.1371/journal.pbio.1001506.g001
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membrane potential and the AP threshold were marginally
increased in Ugcgf/f//CamKCreERT2 mice, however not to an extent
that impairs neuronal function (Figure S2B).
In order to confirm these findings in vitro, immortalized mouse
hypothalamic cells (N-41 cells) expressing GCS-derived ganglio-
sides (Figure S3A,B) were treated with n-butyldeoxynojirimycin
(NB-DNJ) specifically inhibiting GCS [20]. NB-DNJ treatment
resulted in approximately 80%–90% ganglioside depletion (Figure
S3C). Consistent with the findings in Ugcgf/f//CamKCreERT2 mice,
membrane integrity and normal cellular ultrastructure of gangli-
oside-depleted N-41 cells was confirmed by electron microscopy
(Figure S3D). Additionally, passive and active membrane proper-
ties of cultured primary GCS-deficient hypothalamic
Ugcgf/f//NesCre neurons [15] were examined by whole-cell record-
ings. There were no differences toward control cells in membrane
resistance, capacitance, and resting potential (Figure S3E). Spikes
evoked by somatic current injection had unaltered threshold,
amplitude, and duration (Figure S3F). These results indicate that
basic neuronal integrity and general function are not affected by
Ugcg deletion and subsequent lack of plasma membrane gangli-
osides.
Progressive Body Weight Gain, Hypometabolism, and
Hypothermia in Ugcgf/f//CamKCreERT2 Mice
Coinciding with neuronal ganglioside depletion 3 wk p.i. female
and male Ugcgf/f//CamKCreERT2 mice displayed progressive body
weight increase (Figure 2A,B). This phenotype was not detected in
heterozygous mice (Figure S4A), as residual GCS activity
accounted for maintenance of neuronal ganglioside biosynthesis
[15]. Ugcgf/f//CamKCreERT2 mice were larger than control litter-
mates 16 wk p.i. (Figure 2C).
Hematoxylin and eosin (HE) staining revealed enlarged
adipocytes in epigonadal white adipose tissue (WAT) (Figure 2D).
In line with this, epigonadal WAT pad weight was significantly
elevated (Figure 2E). Whole body nuclear magnetic resonance
Figure 2. Ugcgf/f//CamKCreERT2 mice develop progressive obesity. Both female (A) and male (B) Ugcgf/f//CamKCreERT2 mice showed a progressive
increase in body weight after tamoxifen induction (n = 6–9). (C) Ugcgf/f//CamKCreERT2 mice were larger than Ugcgf/f littermates (16 wk p.i.), and body fat
mass was prominently elevated. (D) Enlarged adipocytes in Ugcgf/f//CamKCreERT2 mice 9 wk p.i. (E) Increased weight of epigonadal WAT 9 wk p.i. in
Ugcgf/f//CamKCreERT2 mice (n = 4–5). (F) NMR analysis revealed significant and progressive accumulation of body fat mass in Ugcgf/f//CamKCreERT2 mice
(n = 9–10). *p#0.05; **p#0.01;***p#0.001. Means 6 SEM.
doi:10.1371/journal.pbio.1001506.g002
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(NMR) analysis revealed that body weight increase was due to
progressive accumulation of body fat (Figure 2F); lean mass was
only marginally elevated 4 wk p.i. (Figure S4B). Adjusted for body
weight the initial increase of fat and lean mass was proportional,
whereas at later stages fat mass overrode lean mass gain (Figure
S4C). Liver steatosis and morphological changes in major
peripheral organs of obese Ugcgf/f//CamKCreERT2 mice were not
detected 9 wk p.i. (Figure S4D). Serum enzyme activities
indicative for liver function (glutamate dehydrogenase, glutamic
oxaloacetic transaminase, and glutamic pyruvic transaminase)
were unaltered (Figure S4E). Likewise, serum cholesterol, urea,
glucose, and creatinine did not show any biologically relevant
abnormalities (Figure S4F). Coincident with obesity,
Ugcgf/f//CamKCreERT2 mice were less glucose tolerant than Ugcgf/f
mice 12 wk p.i. (Figure S4G) and insulin sensitivity was marginally
impaired 10 wk p.i. (Figure S4H). These results demonstrate that
Ugcgf/f//CamKCreERT2 mice develop progressive obesity that is
evident in all adipose compartments with constant lean mass and a
shift in body composition toward fat accumulation.
As tight regulation of energy homeostasis is crucial for body
weight maintenance [1], a metabolic characterization was carried
out in order to study the relation of energy intake to energy
expenditure. Food intake and metabolizable energy (EMET)
adjusted to body weight were slightly elevated in
Ugcgf/f//CamKCreERT2 mice before the onset of obesity 3 wk p.i.
(Figure 3A,B) when gangliosides were already depleted in Cre-
targeted brain regions. Hyperphagia was no longer evident 6 and
11 wk p.i., as food intake and EMET were simply elevated due to
higher body weight (Figure 3A,B). Fecal excretion of free fatty
acids (FFAs) as well as energy content of feces and extraction
efficiency from the food (Figure S5A) were unaltered. Thus,
abnormalities in food intake do initially contribute to obesity
development, but not for obesity maintenance.
Energy expenditure was monitored by indirect calorimetry for
21 h. Before onset of body weight gain, the metabolic rate was
indistinguishable from Ugcgf/f mice 2 wk p.i. (Figure S5B). When
adjusted for body weight, the average metabolic rate tended to be
lower in Ugcgf/f//CamKCreERT2 mice at 5 and 9 wk p.i. (Figure 3C).
Spontaneous locomotor activity is one contributor to daily energy
expenditure and has been reported to be decreased in obese
rodents [21]. However, both before the onset of weight gain and
during progressive adiposity, spontaneous open field activity of
Ugcgf/f//CamKCreERT2 mice was indistinguishable from control
littermates (Figure S5C).
The respiratory exchange ratio (RER) provides information on
metabolic fuel preferences [22]. Ugcgf/f//CamKCreERT2 mice
displayed significantly elevated average daily RER values
(Figure 3D). This finding suggests a shift from lipid oxidation
toward lipid storage [22]. In line with this, fat mobilization in
response to fasting as assessed by measuring plasma nonesterified
free fatty acids (NEFAs) was impaired. Significantly decreased
plasma NEFAs were detected in Ugcgf/f//CamKCreERT2 mice 11 wk
p.i. (Figure S5D), suggesting a reduced capability to mobilize lipid
stores when challenged by food withdrawal.
After the onset of weight gain, Ugcgf/f//CamKCreERT2 mice
displayed a prominent drop in core body temperature, as
exemplarily depicted 10 wk p.i. (Figure 3E). Adipocytes in
intrascapular brown adipose tissue (iBAT) were enlarged (Figure
S6A), suggesting reduced triglyceride turnover. Ultrastructural
analysis of iBAT furthermore revealed mitochondrial disorgani-
zation as well as a lower average mitochondrial size (Figure
S6B,C). Thermogenesis in iBAT is regulated by synergistic actions
of thyroid hormones and sympathoadrenergic signaling [23]. Free
triiodothyronine (fT3) and free thyroxine (fT4) levels were normal
in Ugcgf/f//CamKCreERT2 mice (Figure S6D,E). Thus, thyroid
dysfunction was unlikely to account for inappropriate thermoreg-
ulation. Decreased sympathetic outflow to adipose tissue is
assumed to be associated with impaired lipid mobilization [24].
In fact, both iBAT sympathetic activity, as assessed by norepi-
nephrine (NE) turnover rate (Figure 3F, Figure S6F), and NE
content (Figure S6G) were decreased in Ugcgf/f//CamKCreERT2
mice.
These results demonstrate that Ugcgf/f//CamKCreERT2 mice
develop progressive obesity and a shift in body composition
toward fat accumulation initially supported by hyperphagia, but
maintained due to hypometabolism and hypothermia.
Reconstitution of Ugcg Gene Expression in the
Hypothalamic Arc Ameliorates Obesity
Several distinct hypothalamic and nonhypothalamic brain
regions were targeted by Cre activity in Ugcgf/f//CamKCreERT2
mice. Arc neurons in Ugcgf/f//CamKCreERT2 mice expressing the
long form of the ObR were targeted by Cre activity, as
demonstrated by co-immunofluorescence of PStat3 and beta-
galactosidase (b-Gal) in R26R/Ugcgf/+//CamKCreERT2 reporter mice
(Figure 4A). Other leptin-responsive neurons outside the Arc also
targeted by Cre activity, such as the MnPO are likely in part
contributing to the observed phenotype. However, ObR-express-
ing neurons in the LHA seem to be recessed by Cre activity
(Figure S7A,B).
In order to furthermore clarify the role of the Arc in obesity
development, we injected recombinant adeno-associated viruses
encoding either Ugcg and lacZ (rAAV-Ugcg/LacZ) or only lacZ
(rAAV-Empty/LacZ) bilaterally into the Arc of
Ugcgf/f//CamKCreERT2 mice after ganglioside depletion before
4 wk p.i. Injection of rAAV-Ugcg/LacZ significantly ameliorated
obesity, underlining the importance of Ugcg expression in the Arc
for body weight maintenance (Figure 4B). Consistently, serum
leptin levels tended to be lower in rAAV-Ugcg/LacZ-treated mice
(Figure 4C). We verified correct targeting of the Arc by X-Gal
staining of the brains injected with rAAV-Ugcg/LacZ and
displayed targeted regions in a schematic drawing as well as a
typical staining (Figures 4D–F and S7C). Animals that were not
targeted by rAAV-Ugcg/LacZ in the Arc (rAAV-Ugcg/LacZ
missed) did not improve their weight gain (Figure S7D). Restored
ganglioside biosynthesis in the Arc of rAAV-Ugcg-treated animals
compared to mice injected with viruses encoding empty plasmid
was demonstrated by GD1a immunofluorescence (Figure 4G and
Figure S7E).
Taken together, these results indicate that loss of GCS
expression in the Arc is significantly involved in part of the
metabolic deregulation seen in Ugcgf/f//CamKCreERT2 mice.
GCS-Derived Gangliosides Regulate Leptin Receptor
Signaling in Hypothalamic Neurons at the Plasma
Membrane
Since the number of neurons in the Arc did not differ between
Ugcgf/f//CamKCreERT2 mice and controls (Figure S8A), a functional
analysis of the Arc was performed. Leptin signaling in the
hypothalamus is crucial for the maintenance of body weight and
energy homeostasis. As adipocyte-secreted leptin is a major
regulator of body weight in the CNS, we hypothesized that leptin
signaling might be disturbed in GCS-deficient neurons of
Ugcgf/f//CamKCreERT2 mice. In order to test this hypothesis, we
investigated hypothalamic Stat3 phosphorylation (PStat3) in the
Arc after peripheral leptin stimulation. Decreased PStat3 was
detected by immunofluorescence in the Arc (Figure 5A) and by
GCS Regulates ObR in Hypothalamic Neurons
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Figure 3. Obese Ugcgf/f//CamKCreERT2 mice are initially slightly hyperphagic and show hypometabolism and hypothermia. (A) Food
intake per day plotted against body weight of Ugcgf/f//CamKCreERT2 mice was slightly but significantly increased 3 wk p.i. and returned to levels not
significantly different from control littermates 6 and 11 wk p.i. (n = 9) (LM). Individual means. (B) Metabolizable energy per day plotted against body
weight in Ugcgf/f//CamKCreERT2 mice was slightly increased 3 wk p.i. and returned to normal levels 6 and 11 wk p.i. (n = 9) (LM). Individual means. (C)
Metabolic rate of Ugcgf/f//CamKCreERT2 mice was decreased 5 and 9 wk p.i., indicating lower energy expenditure (n = 7–10); p = 0.073 week 5; p = 0.77
week 11 (LM). Individual means. (D) Mean respiratory exchange rate (RER), as determined during a 21-h indirect calorimetry measurement, was
significantly elevated in Ugcgf/f//CamKCreERT2 mice 5 and 9 wk p.i., indicating reduced lipid oxidation (n = 7–10). (E) Rectal temperature measurements
showed a drop in body temperature in Ugcgf/f//CamKCreERT2 mice (10 wk p.i.; n = 9–10). (F) Ugcgf/f//CamKCreERT2 mice showed lower sympathetic activity,
indicated by lower norepinephrine turnover (NETO) rate, in total iBAT pad 9 wk p.i. (n = 4). *p#0.05; **p#0.01;***p#0.001. Means 6 SEM unless
stated otherwise.
doi:10.1371/journal.pbio.1001506.g003
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Western blot in mediobasal hypothalamus (Figure S8B). Interest-
ingly, baseline Stat3 levels were elevated in Ugcgf/f//CamKCreERT2
mice (Figure S8C). The PStat3/Stat3 ratio was decreased both at
baseline and upon leptin challenge (Figure S8D).
It has been shown that deficient ObR signaling due to leptin
resistance of the Arc in mice with diet-induced obesity (DIO) is a
consequence of long-term elevated leptin levels [25–27]. The
suppressor of cytokine signaling 3 (SOCS-3) is a major negative
regulator of the ObR that is elevated in rodent models of leptin
resistance [25,28]. In line with progressive obesity,
Ugcgf/f//CamKCreERT2 mice show indeed elevated leptin levels
7 wk p.i. (Figure 5B). However, expression of hypothalamic Socs-3
did not rise with increasing obesity and leptin levels, as measured
2, 6, and 9 wk p.i. (Figure 5C). Moreover, hypothalamic ObR
expression, usually elevated in leptin-resistant rodents [29,30], was
normal in Ugcgf/f//CamKCreERT2 mice 6 wk p.i. (Figure 5D).
To further investigate if GCS-derived gangliosides regulate
proper leptin receptor signaling at the level of the plasma
membrane in hypothalamic neurons, we first assured that loss of
gangliosides would not interfere with ObR transport to the
membrane, which would have impaired ObR signaling per se.
ObR was labeled by an in situ proximity ligation assay (PLA) on
non-detergent-perturbed cells by two ObR antibodies. The
number of detected surface ObR PLA spots on cells treated with
NB-DNJ was similar to control cells (Figure 5E), indicating that
ObR at the plasma membrane of ganglioside-depleted hypotha-
lamic cells is not significantly changed compared to control cells.
As GCS-derived gangliosides have previously been shown to
modulate the activity of plasma-membrane-located receptors
through close interactions in both adipocytes [17] and neurons
[31], we investigated ObR interactions with major neuronal
gangliosides. The PLA indicating close proximity events [32]
indeed revealed proximity between ObR and gangliosides GM1
and GD1a. In demonstration of activity-dependent interaction
between GSL and ObR, the number of GD1a/ObR and GM1/
ObR PLA spots increased upon stimulation with leptin
(Figures 5F,G and S8E). Complex formation between GD1a/
GM1 with ObR was further corroborated by co-immunoprecip-
itation (Co-IP) of ObR and GD1a/GM1 in saline- and leptin-
stimulated N-41 cells (Figures 5H and S8F). As N-41 cells do not
express the complex neuronal gangliosides GD1b and GT1b,
potential interactions with ObR had to be analyzed in hypotha-
lamic tissue of Ugcgf/f mice. GD1b and GT1b could not be co-
precipitated with ObR (Figure 5H).
Ganglioside-depleted cells were then assessed for leptin-depen-
dent signal transduction. Ganglioside-depleted cells did not show
the leptin-stimulated increased complex formation between ObR
and Jak (Figures 5I and S8G). Time- and dose-dependent Jak
phosphorylation could be induced by leptin treatment in N-41
cells and was decreased in NB-DNJ-treated GSL-depleted cells
(Figures 5J and S8H). It has to be noted that NB-DNJ evokes
ganglioside depletion by only approximately 80%–90% (Figure
S3C). Thus, residual gangliosides in the plasma cell membrane
may explain the appearance of a P-Jak signal at a late time point
after stimulation of NB-DNJ-treated cells. Ganglioside-depleted N-
41 cells showed decreased Jak phosphorylation 30 min after
stimulation with 0.5 mg/ml leptin (Figure 5J,K).
These results have now shown that two major neuronal GCS-
derived gangliosides, GD1a and GM1, form dynamically leptin-
stimulated complexes with ObR on the plasma membrane and
that loss of gangliosides decreases signal transduction in hypotha-
lamic neurons.
Distinct Hypothalamic Neurons of Ugcgf/f//CamKCreERT2
Mice Are Less Responsive to Peripheral Leptin
It is known that mice with deficient leptin receptor (db/db mice)
function develop obesity and lack hypothalamic responsiveness to
leptin stimulation [33]. Regarding the finding that neuronal
gangliosides enhance ObR signaling, we hypothesized that
hypothalamic neuronal function may be altered in
Ugcgf/f//CamKCreERT2 mice. In order to investigate this question,
neuronal activity after intraperitoneal (i.p.) leptin injection was
evaluated by c-Fos staining [34]. Leptin-induced c-Fos formation
was normal in non-obese Ugcgf/f//CamKCreERT2 mice 1–2 wk p.i.
(Figure 6A). Since ganglioside depletion coincides with the start of
the obesity development, Ugcgf/f//CamKCreERT2 mice that were
weight-matched to control littermates were analyzed 3–4 wk p.i.
Decreased leptin responsiveness could already be observed in the
Arc of these mice (Figure 6B) as well as in the Arc of obese mice
6 wk p.i. (Figure 6C).
Neurons in the nontargeted and non-ganglioside-depleted
VMH retained responsiveness to leptin at all time points
(Figure 6D–F). As expected, the nontargeted brain stem NTS of
Ugcgf/f//CamKCreERT2 mice showed regular leptin-induced c-Fos
staining 6 wk p.i. (Figure S9).
Altogether, these results indicate a primary deficiency of
ganglioside-depleted hypothalamic neurons to respond adequately
to peripheral leptin signals.
Ganglioside-Depleted NPY/AgRP and POMC Neurons in
the Arc Are Less Responsive to Leptin
Antagonistic orexigenic NPY and anorexigenic POMC neurons
in the hypothalamic Arc are first-order responsive neurons
initiating metabolic adaptations to altered peripheral leptin levels
[4]. In order to determine leptin-dependent NPY and POMC
neuronal function, neuronal activity and ObR activation were
assessed by semiquantitative analysis of c-Fos, PStat3, and PIP3
formation in response to peripheral leptin injections. Leptin
engaged POMC neurons (a-MSH positive) in control mice, as
indicated by increased c-Fos (Figure 7A). Significantly elevated
PStat3 (Figure 7B) and PIP3 formation (Figure S10A) confirmed
activation of their ObR. Before ganglioside depletion (1–2 wk p.i.),
POMC neurons of Ugcgf/f//CamKCreERT2 mice responded normally
to leptin. However, c-Fos, PStat3, and PIP3 formation were not
elevated in response to leptin in obese GSL-deficient mice 6 wk
Figure 4. rAAV-mediated Ugcg gene delivery to the hypothalamic Arc ameliorates obesity and hyperleptinemia in
Ugcgf/f//CamKCreERT2 mice. (A) Double immunofluorescence showed that Cre activity, indicated by beta galactosidase staining (b-gal), was
targeted to Arc neurons expressing the long form of the ObR, as indicated by PStat3 staining in leptin-injected R26R/Ugcgf/+//CamKCreERT2 mice
(5 mg/kg leptin, 120 min). (B) Stereotactic delivery of rAA viruses encoding Ugcg and lacZ to the Arc of Ugcgf/f//CamKCreERT2 mice resulted in a
significant amelioration in body weight increase compared to rAAV-Empty/lacZ-injected Ugcgf/f//CamKCreERT2 mice (n = 6–8). (C) Serum leptin tended to
be lower in rAAV-Ugcg/lacZ-injected Ugcgf/f//CamKCreERT2 mice 8 wk p.i. (n = 6–8). (D–F) Targeting of rAAV Ugcg/lacZ- and rAAV Empty/lacZ-injected
animals that were included in the analyses. At the end of the experiments, brains were removed and stained for X-Gal to indicate vector delivery. Red
marks depict exemplarily areas of strong X-Gal staining in animals considered as Arc targeted. Depicted are areas between bregma 21.9 (D), bregma
22.1 (E), and bregma 22.3 (F). (G) Restored ganglioside biosynthesis in the Arc of rAAV-Ugcg-injected Ugcgf/f//CamKCreERT2 mice, as shown by GD1a
immunofluorescence 8 wk p.i. Scale bar: 18 mm. *p#0.05. Means 6 SEM.
doi:10.1371/journal.pbio.1001506.g004
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p.i. (Figures 7A,B and S10A). No significant changes were found in
mediobasal hypothalamus (MBH) baseline mRNA expression of
Pomc and cocaine- and amphetamine-regulated transcript (Cart)
mRNA 6 wk p.i. (Figure S10B).
While a slight decrease in c-Fos–positive NPY neurons was
found in leptin-injected control mice, leptin did not show any such
effect in Ugcgf/f//CamKCreERT2 mice 6 wk p.i. (Figure 7C). Simi-
larly, leptin did not raise PStat3 levels in NPY neurons of
Ugcgf/f//CamKCreERT2 mice 6 wk p.i. (Figure 7D) and did not have
any direct effect on PIP3 formation (Figure S10C). Remarkably,
basal mRNA expression of Agrp and Npy was markedly elevated in
the MBH of Ugcgf/f//CamKCreERT2 mice 6 and 9 wk p.i., with Agrp
already increasing 2 wk p.i. (Figure S10D).
In summary, this study has indicated that GCS expression and
sufficient gangliosides in neurons of the adult CNS play a seminal
role in the regulation of body weight and energy homeostasis.
Analysis of the leptin receptor signaling pathway, being one of the
most prominent regulators of CNS metabolic control [35,36],
revealed that GCS-derived gangliosides interact with ObR on the
plasma cell membrane, thereby facilitating ObR-dependent signal
transduction (Figure 8A). In Ugcgf/f//CamKCreERT2 mice, leptin
responsiveness and neuronal function are impaired in hypotha-
lamic neurons involved in the regulation of energy metabolism
(Figure 8B). Consequently, defective ObR signaling contributes to
the observed metabolic imbalance and obesity development of
mice with ganglioside deficiency in the CNS.
Discussion
Although the seminal role of CNS feedback responses to
peripheral energy signals for the regulation of energy homeostasis
has been extensively studied, the role of the lipid microenviron-
ment for energy signal receptor function has not yet been
addressed. The present study demonstrates that GCS-derived
GSLs are critically involved in a to-date unknown mechanism of
hypothalamic control of body weight. In line with the finding that
neurons of the constitutive Ugcgf/f//NesCre mice do not show
increased apoptosis [15], ganglioside-deficient hypothalamic neu-
rons are viable and they show normal membrane and organelle
appearance both in vivo and in vitro. Electrophysiological
recordings from Arc neurons in slices of Ugcgf/f//CamKCreERT2
mice at 12 wk p.i. did not show a major disruption of membrane
functions. However, resting membrane potential and action
potential threshold were both shifted to slightly more depolarized
values. The molecular mechanism underlying the altered mem-
brane potential remains presently elusive. However, it is well
feasible that the shift of threshold is secondary to the slight
depolarization, which might inactivate a fraction of Na+ channels.
In line with the largely normal properties of neurons from brain
slices, biophysical parameters of primary hypothalamic neurons
devoid of gangliosides were unaltered. Thus, failure of basic
electrophysiological membrane functions is unlikely to cause the
observed phenotype of mice with ganglioside deficiency.
Therefore, the present work focuses on interactions of leptin
receptors with the ganglioside-containing lipid microevironment in
which receptors are embedded. We show with independent
methods that two major neuronal GCS-derived gangliosides,
GD1a and GM1, closely interact with leptin receptors on the
neuronal membrane. This interaction is dynamically enhanced by
stimulation with leptin. Both Ugcgf/f//CamKCreERT2 mice and
ganglioside-depleted hypothalamic cells display deficient ObR
signal transduction upon leptin stimulation, as assessed by
decreased leptin-induced Jak phosphorylation, Stat3 phosphory-
lation, and PIP3 formation. Corroborated in situ by deficient
leptin responsiveness in Arc neurons of Ugcgf/f//CamKCreERT2 mice,
these results indicate that GCS-derived GSLs, primarily ganglio-
sides, are seminal regulators for neuronal leptin signal transduc-
tion. Consequently, Ugcgf/f//CamKCreERT2 mice with deficient
leptin-induced hypothalamic neuronal responsiveness develop
progressive obesity.
Numerous hypothalamic feedback systems involved in body
weight maintenance are known [1,4]. Admittedly, the robust
phenotype of Ugcgf/f//CamKCreERT2 mice may be caused by several
peripheral hormones and defective ensuing signaling events
occurring in various Cre-targeted CNS regions of this mouse
model. The brain stem NTS, though an important mediator of
metabolic control [37], is not targeted by activity under the CamK
II alpha-dependent Cre recombinase used in this study. Conse-
quently, the NTS shows normal responsiveness to leptin in obese
Ugcgf/f//CamKCreERT2 mice and can be excluded to contribute to
the observed phenotype. Recent reviews also highlight the LHA as
an important regulator of energy balance [38,39]. In fact,
compensating neurocircuits involving nontargeted CNS regions
may be considered for the return of food intake from initial
hyperphagia to normal levels in obese mice despite the striking
increase in orexigenic neuropeptides. Even though X-Gal staining
could be seen in parts of the LHA, we could not verify Cre
targeting of a major part of ObR-expressing LHA neurons in
Ugcgf/f//CamKCreERT2 mice (Figure S7B). In strong support to this
line of reasoning, we demonstrate that partial Ugcg replenishment
in the Arc mediated by stereotactic injection of rAAV significantly
Figure 5. GCS in hypothalamic neurons regulates neuronal leptin signaling at the plasma membrane. (A) Stat3 phosphorylation was
markedly decreased in Arc sections of Ugcgf/f//CamKCreERT2 mice in response to peripheral leptin (5 mg/kg; 45 min) 6 wk p.i. (n = 16–33). Three
independent animal groups were analyzed. (B) Serum leptin levels were unchanged 3 wk p.i. and increased prominently 7 wk p.i. in
Ugcgf/f//CamKCreERT2 mice, reflecting increased body fat mass (n = 12–14). (C) mRNA expression analysis for suppressor of cytokine signaling 3 (SOCS-3)
expression in Arc-enriched hypothalamic tissue was carried out 2, 6, and 9 wk p.i. Socs-3 expression normalized to the housekeeping gene tubulin
was unaltered (n = 3–5). (D) mRNA expression analysis for the long form of the leptin receptor, Leprb, in mediobasal hypothalamus was carried out
6 wk p.i. Leprb expression normalized to the housekeeping gene tubulin was unaltered at that time point (n = 4–5). (E) Immortalized mouse
hypothalamic cells (N-41 cells) were analyzed for cell surface expression of ObR. Non-detergent-treated cells were fixed and simultaneously stained
with two ObR antibodies. A proximity ligation assay (PLA) indicated quantifiable and unchanged ObR expression on the surface of controls and cells
treated with the specific GCS inhibitor NB-DNJ (n = 41–47 cells). PLA principle is depicted on the right side. (F–G) N-41 cells were incubated with either
saline or 100 ng/ml leptin (10 min). Close interactions between GCS-derived neuronal gangliosides GD1a/ObR (F) and GM1/ObR (G) were detected by
PLA. Leptin treatment dynamically increased the GD1a/ObR and GM1/ObR PLA spots per cell (n = 48–67 cells). (H) Extracts from saline- and leptin-
treated N-41 cells were immunoprecipitated with an ObR antibody, lipids were extracted, and GD1a and GM1 were visualized by immune overlay TLC.
GD1a and GM1 co-immunoprecipitated (Co-IP) with ObR, which tended to be stronger in leptin-treated cells. Addition of a blocking peptide almost
totally abolished ganglioside signals. Gangliosides GD1b and GT1b, expressed in mouse brain tissue, were not co-precipitated with ObR from
hypothalamic tissue of Ugcgf/f mice (5 mg/kg leptin, 45 min). (I) Co-IP showed significantly decreased leptin-induced complex formation between
ObR and Jak in NB-DNJ-treated N-41 cells (n = 4). (J) Sustainable Jak phosphorylation could be induced in N-41 cells after 15 min of leptin treatment
(0.5 mg/ml). NB-DNJ-treated cells showed a markedly delayed response to leptin. (K) Thirty minutes after leptin treatment, Jak phosphorylation was
decreased in NB-DNJ-treated cells (n = 4). *p#0.05; ***p#0.001. Means 6 SEM.
doi:10.1371/journal.pbio.1001506.g005
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Figure 6. Hypothalamic neurons of Ugcgf/f//CamKCreERT2 mice are less responsive to peripheral leptin. (A–C) Brains of leptin-stimulated
mice were analyzed for neuronal activity indicated by c-Fos immunofluorescence. Detailed pictures in the upper lane indicate regions of the Arc that
are outlined in overview pictures (frames). Arrowheads mark c-Fos-positive neurons located in the VMH. Axis indicators were included indicating the
medial (m) and ventral (v) axes. (A) Ugcgf/f//CamKCreERT2 mice showed leptin-induced neuronal activation comparable to Ugcgf/f mice in the Arc 1–2 wk
p.i. (B) Leptin response in the Arc was decreased in nonobese Ugcgf/f//CamKCreERT2 mice weight-matched to controls 3–4 weeks p.i. (C) Decreased c-Fos
staining in the Arc was also observed in obese leptin-induced Ugcgf/f//CamKCreERT2 mice 6 wk p.i. The percentage of c-Fos-positive neurons per Arc
section was depicted as values normalized to saline-injected Ugcgf/f mice (n = 14–22 sections). Depicted sections are located between bregma levels
21.5 to 21.8. Quantification contains data from bregma levels 21.4 to 22.3. (D–F) Ugcgf/f//CamKCreERT2 mice retained leptin responsiveness in the
VMH, as elevated c-Fos after leptin stimulation indicated (n = 8–20 sections). Quantification contains data from bregma levels 21.4 to 22.0. Datasets
for each time point were acquired individually. Two (1–2 and 3–4 wk) or three (6 wk) independent animal groups were analyzed.
Immunofluorescence and image acquisition for each dataset (treated and untreated controls and knockouts) were performed simultaneously.
Scale bar: 75 mm; 3rdv, 3rd ventricle; *p#0.05; **p#0.01; ***p#0.001. Means 6 SEM.
doi:10.1371/journal.pbio.1001506.g006
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ameliorates obesity and hyperleptinemia in Ugcgf/f//CamKCreERT2
mice. Even though limited infection of closely attached tissue by
rAAV injection could not be definitely excluded, mainly Arc
neurons were targeted by this approach, as assessed by X-Gal
stainings of brains co-injected with LacZ-expressing viruses. The
present investigation has thus been restricted to GCS effects
focused on the MBH harboring Arc neurons.
Deficient leptin signaling as a consequence of leptin resistance
occurs predominantly in the Arc of DIO mice with severe long-
term hyperleptimenia [25–27,40]. Socs-3 is a major negative
feedback pathway of ObR signaling [41]. Thus, elevated Socs-3
expression levels are found in the hypothalamus of leptin-resistant
rodent models [25,42]. In line with observations in obese db/db
mice with nonfunctioning ObR [25,42], Socs-3 expression in the
Arc remains indistinguishable from control littermates in nonobese
and obese Ugcgf/f//CamKCreERT2 mice 2, 6, and 12 wk p.i. Elevated
hypothalamic ObR expression, as it occurs in DIO mice [29,30],
has also been proposed as a potential mechanism playing a role in
the development of leptin resistance [28]. However, normal ObR
expression in Ugcgf/f//CamKCreERT2 mice supports the hypothesis
Figure 7. POMC and NPY neurons of Ugcgf/f//CamKCreERT2 mice are less responsive to leptin. (A) Leptin engages POMC neurons in the Arc of
control (Ugcgf/f) mice and Ugcgf/f//CamKCreERT2 mice 1–2 wk p.i., as indicated by elevated c-Fos. This response was decreased in Ugcgf/f//CamKCreERT2 mice
6 wk p.i. (B) Elevated leptin-induced PStat3 levels in POMC neurons of Ugcgf/f mice and Ugcgf/f///CamKCreERT2 mice 1–2 wk p.i. This response was
blunted in Ugcgf/f//CamKCreERT2 mice 6 wk p.i. (C) Leptin slightly decreased the activity of NPY neurons in Ugcgf/f mice and Ugcgf/f///CamKCreERT2 mice 1–
2 wk p.i. This was not detected in Ugcgf/f///CamKCreERT2 mice 6 wk p.i. (D) Unlike 1–2 wk p.i., leptin did not elevate PStat3 in NPY neurons of
Ugcgf/f///CamKCreERT2 mice 6 wk p.i. Datasets for each time point were acquired individually, and quantification contains normalized data from two (1–
2 wk p.i.; n = 4–11) or three (6 wk p.i.; n = 18–27) independent animal groups. Immunofluorescence and image acquisition for each dataset (treated
and untreated controls and knockouts) were performed simultaneously. Scale bar: 20 mm; *p#0.05; **p#0.01; ***p#0.001. Means 6 SEM.
doi:10.1371/journal.pbio.1001506.g007
Figure 8. Proposed model for GCS-derived ganglioside GD1a and GM1 regulation of hypothalamic leptin signaling and energy
homeostasis. (A) GCS-derived gangliosides form complexes with ObR, thereby facilitating leptin-dependent Jak and Stat3 phosphorylation, and
formation of PIP3. These pathways are crucial contributors to regulation of energy homeostasis. (B) In obese Ugcgf/f//CamKCreERT2 mice, ObR signal
transduction is abolished in GCS-depleted neurons.
doi:10.1371/journal.pbio.1001506.g008
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that the ObR signaling in their neurons must be deficient due to
ganglioside loss and not merely due to secondary leptin resistance.
Furthermore, the nontargeted hypothalamic VMH and brain stem
NTS retain leptin responsiveness even in obese mice 6 wk p.i.
These results in combination with the decreased ObR signal
transduction in ganglioside-depleted and non-leptin-resistant N-41
cells strongly suggest that loss of GCS-derived GSLs including
gangliosides GD1a and GM1 is the reason for failing ObR
activation and subsequently inhibited intracellular signaling.
GCS-depleted Arc neurons display normal leptin sensitivity 1–
2 wk p.i., a time point when gangliosides are still present.
Furthermore, onset of body weight gain, deficient neuronal
activity in the Arc, and abolished ObR signaling coincide with
ganglioside depletion 3 wk p.i. This strongly suggests that the
mentioned defects are due to ganglioside depletion in these cells
rather than due to lack of the enzyme GCS itself.
Further evidence for the postulate that ganglioside deficiency-
dependent inhibition of ObR signaling in hypothalamic neurons
leads to impaired neuronal function is based on our in situ results
in ganglioside-depleted Arc of both obese and nonobese
Ugcgf/f//CamKCreERT2 mice. Whereas leptin injection increases c-
Fos immunoreactivity and thus neuronal activity in the Arc
neurons of fasted lean mice, this response did not occur in GCS-
deficient neurons. Leptin specifically engages POMC neurons.
Even though the effects of PI3k- and Stat3-dependent signaling in
POMC neurons do not overlap [12,43], both pathways are
activated by leptin [11,12,44,45] and contribute to maintenance of
energy homeostasis [46]. In ganglioside-depleted POMC neurons,
neither PStat3 nor PIP3 formation is increased by peripheral
leptin injections, strongly suggesting that defects in both pathways
may contribute to partial failure of obesity prevention. As
peripheral leptin stimulates both pathways through ObR activa-
tion [11,47], defective ObR function is very likely to be assumed.
In NPY neurons, it has been demonstrated that Jak-Stat3
signaling plays an important role in maintaining NPY/AgRP-
mediated energy homeostasis [48]. Additional ObR-mediated
PI3k activation seems to be required for inhibiting Npy and Agrp
gene expression [8]. Npy and Agrp expression is markedly increased
in the MBH of Ugcgf/f//CamKCreERT2 mice, which may be a
consequence of absent leptin-induced PStat3 formation in NPY
neurons. On the other hand, leptin-induced PIP3 formation does
not differ in neither of the groups, which goes in line with the
hypothesis that leptin-dependent PIP3 formation in AgRP/NPY
neurons is stimulated by an indirect mechanism involving synaptic
transmission [12]. Overactive NPY neurons in obese ObR-
deficient Leprfa/fa rats were shown to inhibit sympathetic nervous
outflow to BAT and cause hypothermia [7] as observed in
Ugcgf/f//CamKCreERT2 mice. With regard to the fact that Npy and
Agrp but not Pomc expression differ in Ugcgf/f//CamKCreERT2 mice,
the role of GCS expression in regulating neuropeptide expression
and secretion has to be elucidated. Especially the role of
hypothalamic insulin receptor signaling, which also regulates the
expression of Pomc and Npy/Agrp in part similar to ObR signaling
[11] and is antagonized by GM3 in the periphery [17], constitutes
a promising target for further clarifying the differential neuropep-
tide expression. Moreover, a potential contribution of Cre-
targeted ObR-expressing neurons in the median preoptic area of
Ugcgf/f//CamKCreERT2 mice to hypothermia may also be
considered.
Dynamic membrane microdomains are widely accepted as
critical components involved in membrane receptor functions
[16,49]. Since GCS-derived gangliosides are important constitu-
ents of these microdomains, they potentially interact with and
regulate a variety of membrane components including receptors
such as Trk receptors [31] and insulin receptors [17]. In contrast
to mice with neuron-specific insulin receptor deletion, which only
display a gender- and diet-dependent subtle increase in body
weight [11,50], the obesity and glucose intolerance observed in
db/db mice can be rescued by neuron-specific re-expression of
ObR [51]. Furthermore, deficient ObR signaling in POMC
neurons of the Arc itself leads to the development of mild obesity
[52]. In consideration of these findings—despite the existence of
potential alternative pathways that might be impaired in neurons
of Ugcgf/f//CamKCreERT2 mice—we ascribe ObR and its regulation
of activity to a major function in our model pointing to a novel
mechanism for CNS metabolic regulation.
We demonstrate that GCS-derived gangliosides GD1a and
GM1 closely interact with ObR. The leptin-induced increase in
GD1a/ObR and GM1/ObR interaction assumes recruitment of
these gangliosides to the ObR upon leptin stimulation. These
results in combination with the demonstrated deficient ObR
signaling in ganglioside-depleted hypothalamic neurons both in
vivo and in vitro leads us to surmise that the lipid microenviron-
ment surrounding the ObR can significantly modulate leptin-
dependent intracellular signal transduction in hypothalamic
neurons. Altogether, these results provide evidence that GM1
and GD1a are actively involved in enhancing the effects of leptin
in hypothalamic neurons.
As insulin receptors contain a lysine residue predicted for
interaction with GM3 [53], loss of GM3 synthase showed already
a prominent effect on peripheral insulin receptor signaling [17]. It
is a widely accepted concept that in the state of insulin resistance in
peripheral adipocytes, the IR segregates from caveolae into GM3-
enriched microdomains [53], an endogenous inhibitory mecha-
nism [17]. Indeed, elevated GM3 synthase expression could be
detected in adipose tissue of obese Zucker fa/fa rats and ob/ob mice
[54]. Pharmacologic GCS inhibition in the periphery has been
shown to exert beneficial effects on peripheral insulin sensitivity
and liver steatosis [55,56]. With regard to the fact that different
ganglioside species can exert either stimulatory [18,57] or
inhibitory [17] effects on membrane receptors, the mentioned
studies including the present work support the concept that any
perturbation, either loss or excess, of membrane GSLs can alter
receptor function. Contributions of GCS-derived lipid raft
components apart from gangliosides, namely neutral GSLs in
the CNS, to leptin receptor function have yet to be elucidated and
constitute a challenging target for future investigations. Besides
gangliosides, lactosylceramide has been shown to contribute to
formation of lipid microdomains [58]. We, however, propose in
the present study that in line with the findings for the insulin
receptor, hypothalamic leptin receptor signaling is to a significant
extent regulated through interactions with the dominant gangli-
osides GD1a and GM1.
Recent studies have highlighted the central role of systemic
ceramide biosynthesis and GCS in the regulation of energy
homeostasis [59,60]. In accordance with earlier findings [15,61],
we show that neuronal ceramide levels in Ugcgf/f//CamKCreERT2
mice are indistinguishable from control mice, virtually excluding
any effects of ceramides.
In conclusion, our study highlights the expression of neuronal
GCS-derived GSLs, foremost gangliosides, as a novel class of
hypothalamic metabolic regulators. Gangliosides GM1 and GD1a
enhance the action of leptin on intracellular signaling and
neuronal activity, most likely through dynamic changes of the
lipid microenvironment of the ObR. We demonstrate by
independent methods that gangliosides GD1a and GM1 strongly
interact with the ObR upon leptin stimulation. Loss of these
gangliosides leads to impaired responsiveness. By this relevant
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influence on hormone signaling, Ugcg deletion in adult mouse CNS
leads to development of progressive obesity, hyperleptinemia, and
glucose intolerance. The obesity can be partially ameliorated by
restoration of GCS activity and ganglioside expression in the
hypothalamic Arc of Ugcgf/f//CamKCreERT2 mice. Neuronal GCS
expression therefore constitutes a novel mechanism for hypotha-
lamic regulation of body weight maintenance.
Materials and Methods
Ugcgf/f//CamKCreERT2 Mice
Animals were kept in specific-pathogen-free barrier facilities.
Ugcgf/f mice [15] and inducible CamKCreERT2 mice were bred
to generate Ugcgf/f//CamKCreERT2 mice and control littermates.
Mice were induced with tamoxifen 6 wk after birth for 1 wk as
described [19]. We performed experiments in female mice, unless
stated otherwise.
Glucose Tolerance and Insulin Sensitivity
Mice were fasted overnight (o/n). Blood glucose levels were
analyzed prior to i.p. injection of glucose (2 g/kg body weight).
Glucose levels were determined from tail vein blood (Glucometer
Accu Check, Aviva, Roche). Food was withdrawn 4 h prior to the
insulin sensitivity assay. Mice were injected i.p. with 0.75 U/kg
human insulin (Eli Lilly), and glucose levels were determined as
described above (see also Text S1).
GD1a Immunofluorescence
Staining was carried out as described earlier [62]. Cryosections
(male mice) were incubated with mouse-a-GD1a (1:100, Millipore)
followed by secondary donkey-a-mouse-Alexa-Fluor 488 (1:200,
Invitrogen). Analysis was performed by confocal microscopy
(TCS-SL, Leica).
Leptin Injections and Double-Immunofluorescence
Mice were fasted o/n and injected with leptin (5 mg/kg,
Peprotech) or saline between 8.00 a.m. and 10.00 a.m. Animals
were sacrificed at indicated time points and transcardially perfused
with 4% paraformaldehyde (PFA). We prepared 40 mm cryosec-
tions covering the Arc. Alternating sections were collected in series
for subsequent free-floating section immunostainings. First anti-
bodies used for immunostaining were rabbit-a-PStat3 (1:100, Cell
Signaling Technology), rabbit-a-c-Fos (1:100, Santa Cruz), and
FITC-conjugated a-PIP3 (1:100, Echelon). Secondary antibody
was donkey-a-rabbit-Alexa-Fluor 488 (1:200, Invitrogen). Sections
were subsequently incubated with either goat-a-NPY (1:50, Santa
Cruz) or sheep-a-MSH (1:1000, Millipore) followed by secondary
antibodies (donkey-a-goat-Alexa-Fluor 546, donkey-a-sheep-
Alexa-Fluor 546, 1:200, Invitrogen). Stainings were analyzed by
confocal microscopy (TCS-SL, Leica). Neurons with nuclear (c-
Fos, PStat3) or cytoplasmic (PIP3, NPY, and a-MSH) staining
above background were considered positive. Immunofluorescence
for beta galactosidase was performed as described earlier [63].
Generation of rAAV
The AAV Helper-free System (Agilent Technologies Inc.) was
used for preparation of rAAV. Full-length mouse Ugcg cDNA was
cloned into the pAAV-MCS vector from the Helper-free System
(pAAV-Ugcg). Viruses were generated according to the manufac-
turer’s guidelines and purified as described earlier [64].
rAAV Injection Into the Arc
Bilateral stereotaxic injections were performed as described
[65]. We injected 400 nl virus solution containing equal volumes
of viruses carrying Ugcg and lacZ (,1.8*1011 genome copies/ml)
into the Arc of each hemisphere (caudal to bregma: 1.4 mm,
1.44 mm; lateral: 0.25 mm; ventral: 5.7 mm). After surgery, mice
were maintained with ad libitum access to lab chow and body
weight was monitored weekly.
Immortalized Hypothalamic Cell Culture (N-41cells)
Immortalized hypothalamic neurons were purchased from
CELLutions Biosystems (mHypoE N-41, Cedarlane) and cultured
according to the manufacturer’s guidelines. GCS was inhibited
with NB-DNJ treatment (100 mM, 7 d, Sigma; Tocris).
Proximity Ligation Assay (PLA)
Eight thousand N-41 cells were seeded onto coverslips and
incubated at 37u o/n. The 3 h serum-starved cells were stimulated
with leptin (100 ng/ml, Peprotech) for 10 min, washed with PBS
and fixed in 4% PFA for 15 min. Cells were blocked with 5% skim
milk/PBS. PLA was performed with primary antibodies against
ObR (1:50, Santa Cruz), GD1a (1:100, Millipore), and GM1 (1:10,
Matreya). PLA was performed according to the manufacturer’s
guidelines (Duolink Orange Detection System, Olink Biosciences).
Formation of PLA spots was analyzed by fluorescence microscopy
(Zeiss Cell Observer).
Western Blot
Mice were injected with leptin or saline as described above and
sacrificed 30 min later. The MBH was dissected homogenized on
ice in lysis buffer (20 mM HEPES, 25 mM KCl, 250 mM sucrose,
2 mM MgCl2, 0.5 mM DTT, 1% digitonin) containing proteinase
inhibitor (Roche) and phosphatase inhibitor cocktail (Sigma).
Immortalized hypothalamic cells were treated with either saline or
100 mM NB-DNJ for 7 d, serum starved for 4 h, and subsequently
treated with either saline or leptin (1,000 ng/ml, Peprotech, 1 h).
Cells were lysed on ice in lysis buffer. Protein concentrations were
determined by Bradford assay (Sigma). Western blots were
performed as described earlier [25]. Primary antibodies: rabbit-
a-PStat3, rabbit-a-Stat3, rabbit-a-PJak, rabbit-a-Jak (1:1,000, Cell
Signaling Technology), mouse-a-tubulin (1:5,000, Zymed Labs),
and rabbit-a-actin (1:1,000, Santa Cruz). Secondary antibodies:
HRP-conjugated a-rabbit-IgG (1:1,000, Dako) and HRP-conju-
gated a-mouse-IgG (1:5,000, Santa Cruz). Bands were visualized
by chemiluminescence (Amersham) and quantified (ImageJ, NIH).
Co-Immunoprecipitation (Co-IP)
Four hours serum-starved N-41 cells were treated with leptin
(1,000 ng/ml, 25 min). Cells were lysed in IP buffer [50 mM
HEPES, pH 7.0, 150 mM NaCl, 10% glycerol, 1% Triton-X,
1.5 mM MgCl2, 1 mM EDTA, proteinase inhibitor cocktail
(Roche)]. Co-IP for ObR/Jak was performed as described earlier
[36]. ObR/GD1a- and ObR/GM1-Co-IP and subsequent lipid
extraction and analysis was performed as described earlier [31,53].
Anti-ObR were incubated at 4uC o/n. Immunoprecipitated lipids
were desalted on an RP-18 column, spotted on a TLC, and run in
solvent (chloroform/methanol/0.2% CaCl2; 60:35:8, by vol.).
GD1a was visualized with mouse a-GD1a (1:1,000, 4uC overnight,
Millipore) on the TLC by immune overlay staining as described
earlier [66].
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Measurement of Serum Leptin and Nonesterified Free
Fatty Acids (NEFAs)
Serum leptin and NEFAs were determined by commercially
available kits according to the manufacturer’s guideline [Leptin-
ELISA (Linco); NEFA-HR2 kit (WAKO Chemicals)]. NEFAs
were measured in male mice.
Determination of NETO and NE Content in iBAT
NETO rate in iBAT was determined as described earlier [67].
Tissue NE was measured by reversed-phase HPLC with electro-
chemical detection (Chrome Systems, Germany) (see also Text S1).
Metabolic Characterization, Core Body Temperature, and
Locomotor Activity
Body weight was measured once a week. Metabolic measure-
ments were carried out in an open circuit respiratory system (SM-
MARS, Sable Systems, USA). VO2 and VCO2 per mouse were
analyzed for 21 h to determine the RER = VCO2/VO2 and HP
(mW). Whole body composition was determined by noninvasive
NMR analysis (Mini-Spec, Bruker Optics). Core body temperature
was measured with a rectal probe (ALMENO 2390-1, Ahlborn)
(see also Text S1).
Quantitative mRNA Analysis
Total RNA of the MBH was extracted from nonfasted mice as
described earlier [68]. RNA was reversely transcribed by
Superscript II Reverse Transcriptase (Invitrogen) and cDNA was
quantified using the LC FastStart DNA Master SYBR Green I kit
(Roche) according to the manufacturer’s guidelines and the Light
Cycler (Roche) (see also Text S1).
X-Gal Stainings
R26R/Ugcgf/+//CamKCreERT2 mice and R26R/Ugcgf/+ mice were
induced with tamoxifen i.p. 6 wk after birth as described. At 3 d
p.i., animals were sacrificed, and brains were removed and frozen
on dry ice. X-Gal staining was performed as described previously
[69]. Similarly, b-galactosidase activity in brains of rAAV-Ugcg/
LacZ-, rAAV-Empty/LacZ-, and rAAV-LacZ-injected mice was
visualized 7 d after virus injection.
Extraction and Analysis of GSLs and Ceramide
GSLs were extracted and separated into neutral and acidic
fractions containing gangliosides as described earlier [15]. The
amount of GSLs spotted onto a plate by a TLC applicator
(Camag, USA) was normalized to tissue protein content
determined by the Lowry method [70]. TLC running solvent for
acidic GSL was chloroform/methanol/0.2% CaCl2 (45:45:10 by
vol). GSLs were visualized with 0.2% orcinol in 10% sulphuric
acid at 120uC for 10 min. Ceramide was extracted as described
earlier [15] and spotted onto a TLC plate. Running solvent for
ceramide was chloroform/methanol/acetic acid (190:9:1 by vol),
and ceramide was visualized with 10% CuSO4 in 8% H3PO4 at
180uC for 10 min. Lipid content was quantified by densitometry
(Shimadzu, Japan).
Statistical Analysis
Unless stated elsewhere, results were analyzed by a two-tailed,
unpaired Student’s t test (Graph Pad Prism, Graph Pad Software,
Inc.). To analyze main effects of genotype on metabolizable energy
or energy expenditure, body weight was employed as a co-factor in
a linear regression model to account for the confounding effect of
body size on energy metabolism parameters [71]. p#0.05 was
considered statistically significant and marked *. p#0.01 was
marked **, and p#0.001 was marked ***.
Supporting Information
Figure S1 Generation and characterization of inducible
Ugcgf/f//CamKCreERT2 mice. (A) R26R/Ugcgf/+//CamKCreERT2 re-
porter mice and R26R/Ugcgf/+ mice were induced with tamoxifen
and brains were removed 3 d after the last injection. X-Gal
staining revealed Cre activity in hypothalamic MnPO, paraven-
tricular nucleus (PVN), and lateral hypothalamus (LH). Cre
activity was absent in ventromedial hypothalamus (VMH) and in
the brain stem nucleus of the solitary tract (NTS; cc, central canal).
Cre activity could be detected in hippocampus and cerebral
cortex. GD1a immunofluorescence visualized ganglioside deple-
tion in Cre-targeted regions of male Ugcgf/f//CamKCreERT2 mice
(6 wk p.i). Scale bar: 100 mm. (B) Overview of brain slices from
R26R/Ugcgf/+//CamKCreERT2 reporter mice indicating Cre activity.
3v, 3rd ventricle; CP, caudoputamen; LSN, lateral septal nucleus;
SFO, subfornical organ; CTX, cortex; HC, hippocampus; DMH,
dorsomedial hypothalamus. (C) In situ hybridization showed
depletion of Ugcg mRNA in hypothalamic PVN (a), SCN (b), as
well as in the amygdala (c), hippocampus (d), and cerebral cortex
(e) of male Ugcgf/f//CamKCreERT2 mice (4 wk p.i.). Respective areas
were visualized by thionine staining. (D) Southern blot did not
show recombination events in peripheral tissues of female
Ugcgf/f//CamKCreERT2 mice 2 wk p.i. The Ugcg null allele could
solely be detected in cerebral cortex, hippocampus, and hypo-
thalamus. (E) Stable ganglioside depletion 3 wk p.i. in targeted
neuronal populations of totally dissected hippocampus as
shown by TLC. Residual gangliosides from nontargeted
cells and innervating fibers were still visible. (+ Ugcgf/f;
2 Ugcgf/f//CamKCre ERT2). Lipid amounts equaling 50 mg of tissue
protein were loaded. Quantification from densitometry analysis of
thin layer chromatography results is depicted (n = 3). (F) Sphingo-
myelin was slightly elevated in hippocampus of
Ugcgf/f//CamKCreERT2 mice. *p#0.05; **p#0.01. Means 6 SEM.
(TIF)
Figure S2 Intrinsic electrical properties of Arc neurons from
brain slices of female Ugcgf/f//CamKCreERT2 mice at 12 wk p.i.
compared to controls. (A) Spontaneous firing frequency (left),
maximal rate of rise of action potentials (AP; middle), and AP
width at half-maximal amplitude (right) were not different between
both strains. (B) Resting membrane potential (RMP, left) and
action potential threshold (right) were both shifted to more
depolarized values in cells from Ugcgf/f//CamKCreERT2 mice. Cell
numbers are stated in brackets above each column. *p#0.05.
Mean values 6 SEM.
(TIF)
Figure S3 Immortalized hypothalamic cells (N-41 cells) express
gangliosides and ganglioside-depleted cells show normal morpho-
logical (N-41) and biophysical membrane properties (primary
Ugcgf/f//NesCre neurons). (A) Ganglioside expression pattern as
determined by TLC after lipid extraction from immortalized
hypothalamic cell lines and subsequent separation of neutral and
acidic glycosphingolipids including gangliosides (St, standard). (B)
Immune overlay TLC confirmed the identity of GD1a and GM3
bands (St, standard). (C) The 7-d treatment of immortalized
hypothalamic cells with the GCS inhibitor NB-DNJ (100 mM) led
to inhibition of ganglioside biosynthesis, as shown by TLC (St,
standard). Quantification of the TLC bands is depicted. (D)
Normal membrane appearance and assessed by electronmicro-
scopy (n, nucleus; nl, nucleoli; m, mitochondria; er, endoplasmic
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reticulum; pm, plasma membrane). Scale bar: 2 mm. (E). Basic
electrophysiological characteristics of primary Ugcgf/f and
Ugcgf/f//NesCre neurons from total embryonic hypothalamus
(E16–E18). Whole-cell recordings from randomly picked neurons
between 7 DIV and 12 DIV. Membrane resistance and
capacitance (tested with a 5 mV test pulse) as well as resting
membrane potential were unaltered in Ugcgf/f//NesCre neurons. (F)
Action potential threshold, amplitude and duration were also
unaltered in Ugcgf/f//NesCre neurons. Data are given as mean
values 6 SEM.
(TIF)
Figure S4 Fat mass in Ugcgf/f//CamKCreERT2 mice was elevated,
while organ morphology was unaltered. (A) Unaltered body weight
in heterozygous Ugcgf/+//CamKCreERT2 mice (n = 4). (B) NMR
analysis revealed that lean mass was only slightly increased 4 wk
p.i. (n = 9–10). (C) Significantly increased body fat mass in
Ugcgf/f//CamKCreERT2 mice 7 and 10 wk p.i. when adjusted for
body weight, as determined by nuclear magnetic resonance
imaging (n = 9–10 per group); **p#0.01 (LM). Individual values.
Relative lean mass, when plotted against body weight, decreased
during progressive weight gain 7 and 10 wk p.i. in
Ugcgf/f//CamKCreERT2 mice (n = 9–10 per group); *p#0.05;
***p#0.001 (LM). Individual values. (D) Unaltered morphology
of major peripheral organs in female mice was shown by
hematoxylin and eosin stainings 9 wk p.i. No liver steatosis could
be detected. (Scale bars: Liver, 50 mm; Kidney, Lungs, Spleen,
200 mm). (E) Parameters indicative for liver function did not show
any significant changes 19 wk p.i., indicating normal liver function
in Ugcgf/f//CamKCreERT2 mice (n = 12; GOT, n = 4). (F) Serum
levels for cholesterol, fasted glucose, urea, and creatinine 19 wk
p.i. did not show any biologically relevant differences in mice
(n = 12). (G) Ugcgf/f//CamKCreERT2 mice displayed impaired glucose
tolerance 12 wk p.i. (n = 9; Mann-Whitney Rank Sum Test). (H)
Slight but significant insulin insensitivity was detected in
Ugcgf/f//CamKCreERT2 mice 10 wk p.i. (n = 8–9; Mann-Whitney
Rank Sum Test). *p#0.05; **p#0.01; ***p#0.001. Means 6 SEM
unless stated otherwise.
(TIF)
Figure S5 Normal excretion and unaltered spontaneous loco-
motor activity in Ugcgf/f//CamKCreERT2 mice, but plasma NEFAs
are altered. (A) Fecal free fatty acids (8 wk p.i.), fecal energy
content, and assimilation coefficient were not altered in
Ugcgf/f//CamKCreERT2 mice 3, 6, and 11 wk p.i. Means 6 SEM.
(B) Metabolic rate of Ugcgf/f//CamKCreERT2 mice was unaltered
2 wk p.i. (n = 7–10). Individual means. (C) Spontaneous locomotor
activity measured at different time points after tamoxifen
induction did not reveal any statistically significant difference
between Ugcgf/f//CamKCreERT2 mice and control littermates (n = 9)
(Mann-Whitney Rank Sum Test). Medians and individual values.
(D) Decreased plasma NEFA values in fasted Ugcgf/f//CamKCreERT2
mice 11 wk p.i., indicating decreased fat mobilization (n = 4–6).
**p#0.01. Means 6 SEM.
(TIF)
Figure S6 Hypothermia in Ugcgf/f//CamKCreERT2 mice is not due
to defective thyroid function, but decreased sympathetic activity in
iBAT. (A) Enlarged lipid droplets were found in iBAT of
Ugcgf/f//CamKCreERT2 mice 9 wk p.i. (B) Altered mitochondrial
density and size were detected in Ugcgf/f//CamKCreERT2 mice by
ultrastructural analysis of iBAT 9 wk p.i. (C) Mitochondrial area
was reduced in Ugcgf/f//CamKCreERT2 mice (n = 3 mice, 195
mitochondria). (D) Serum-free thyroxine (fT4) was determined
by ELISA and did not show any alterations in
Ugcgf/f//CamKCreERT2 mice (n = 5–6 per group). (E) Serum-free
triiodothyronine (fT3) was determined by ELISA and did not show
any alterations in Ugcgf/f//CamKCreERT2 mice (n = 3–6 per group).
(F) High performance liquid chromatography (HPLC) revealed
lower sympathetic activity (NETO rate) per mg iBAT 9 wk p.i.
(n = 4). (G) NE content was also decreased in Ugcgf/f//CamKCreERT2
iBAT 9 wk p.i. (n = 4). **p#0.01; ***p#0.001. Means 6 SEM.
(TIF)
Figure S7 rAAV-mediated Ugcg gene delivery to the hypotha-
lamic Arc ameliorates obesity in Ugcgf/f//CamKCreERT2 mice. (A
and B) Double immunofluorescence showed that Cre activity,
indicated by beta galactosidase staining (b-gal), was targeted to
MnPO neurons (A) expressing the long form of the ObR (see
arrowheads), but not to the majority of ObR neurons in the LHA
(B), as indicated by PStat3 staining in leptin-injected
R26R/Ugcgf/+//CamKCreERT2 mice (5 mg/kg leptin, 120 min). (C)
Stereotactic rAAV-LacZ delivery to the Arc was exemplarily
demonstrated by X-Gal-staining. Morphology was depicted in the
HE section. (D) Ugcgf/f//CamKCreERT2 mice that were not targeted
in the Arc by stereotactic delivery of rAA viruses encoding Ugcg
and lacZ did not show improvement in body weight increase
compared to rAAV-Empty/lacZ-injected Ugcgf/f//CamKCreERT2
mice (n = 4 rAAV-Ugcg/lacZ missed, n = 8 rAAV-Empty/lacZ).
The graph depicting rAAV-Empty/lacZ-targeted mice is taken
from Figure 4B for comparison. (E) Restored ganglioside
biosynthesis in the Arc of rAAV-Ugcg-injected
Ugcgf/f//CamKCreERT2 mice, as shown by GD1a immunofluores-
cence 8 wk p.i. Shown are overview pictures for Figure 4G (also
taken for Figure S7E). Scale bar: 18 mm. Means 6 SEM.
(TIF)
Figure S8 GCS in hypothalamic neurons regulates neuronal
leptin signaling. (A) Neuron count in the Arc was normal in
Ugcgf/f//CamKCreERT2 mice (n = 115–122 sections). Quantification
contains normalized data from 12 mice each. (B) Stat3 phosphor-
ylation in MBH of male mice was investigated by Western blot 6 wk
p.i. We loaded 100 mg of protein in each lane. Elevated PStat3 levels
were not seen in Ugcgf/f//CamKCreERT2 mice upon leptin stimulation.
Quantification for PStat3/Tubulin is depicted (n = 3). (C) Baseline
and leptin-stimulated Stat3 levels were elevated in
Ugcgf/f//CamKCreERT2 mice. Stat3 was normalized for tubulin
expression (n = 3). (D) The PStat3/Stat3 ratio is decreased in
Ugcgf/f//CamKCreERT2 mice 6 wk p.i. both at baseline and after leptin
stimulation. PStat3 and Stat3 levels were normalized for tubulin
(n = 3). (E) Immortalized hypothalamic cells (N-41 cells) were
incubated with either saline or 100 ng/ml leptin (10 min). A
proximity ligation assay (PLA; principle depicted in Figure 5E) for
GD1a/ObR similar to the experiment depicted in Figure 5F was
performed using a different ObR-specific antibody. GD1a/ObR
interactions were detected and leptin treatment dynamically
increased the GD1a/ObR PLA spots per cell similar to the result
depicted in Figure 5F. Pre-adsorption of the antibody by a blocking
peptide abolished PLA signals (n = 74–150 cells). (F) Similar to the
experiments depicted in Figure 5H, extracts from saline- and leptin-
treated N-41 cells were immunoprecipitated with a second ObR
antibody, lipids were extracted, and GD1a and GM1 were
visualized by immune overlay TLC. Similar to the results obtained
in Figure 5H, GD1a and GM1 co-immunoprecipitated (Co-IP) with
ObR. (G) Similar to the result in Figure 5I, Jak was co-precipitated
with the ObR, which increased upon leptin stimulation of N-41
cells, using a second ObR antibody. Addition of the blocking
peptide abolished the signal. (H) Weak Jak phosphorylation was
induced in N-41 cells after 30 min of leptin treatment (0.1 mg/ml).
*p#0.05; **p#0.01; ***p#0.001. Means 6 SEM.
(TIF)
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Figure S9 The brain stem NTS of Ugcgf/f//CamKCreERT2 mice
retained leptin responsiveness 6 wk p.i. c-Fos expression was
unaltered in the nontargeted NTS (n = 2–4 sections). Datasets for
each time point were acquired individually. Immunofluorescence
and image acquisition for each dataset (treated and untreated
controls and knockouts) were performed simultaneously. *p#0.05;
**p#0.01. Means 6 SEM.
(TIF)
Figure S10 Reduced PIP3 formation in POMC neurons of
Ugcgf/f//CamKCreERT2 mice upon leptin stimulation. (A) Fasted
mice were injected with either saline or leptin (5 mg/kg body
weight) and sacrificed 45 min later. Either POMC or NPY
staining identified individual neuronal populations. Leptin evokes
PIP3 formation in Arc POMC neurons of Ugcgf/f mice as well as
Ugcgf/f//CamKCreERT2 mice before ganglioside depletion was
completed (1–2 wk p.i.). This response was blunted in ganglio-
side-depleted POMC neurons 6 wk p.i. The percentage of
POMC/PIP3-double-positive neurons per Arc section normalized
to Ugcgf/f saline is depicted (n = 3–7). (B) Unaltered mRNA
expression of the anorexigenic neuropeptides POMC and CART
in the MBH of Ugcgf/f//CamKCreERT2 mice 6 and 9 wk p.i. (n = 3–
6). (C) Fasted mice were injected with either saline or leptin (5 mg/
kg body weight) and sacrificed 45 min later. NPY staining
identified individual neuronal populations. Leptin did not directly
lead to increased PIP3 formation in NPY neurons in neither of the
groups (n = 3–7). (D) Increased Npy and Agrp mRNA expression in
the MBH of Ugcgf/f//CamKCreERT2 mice 6 and 9 wk p.i. (n = 3–6).
Datasets for each time point were acquired individually.
Immunofluorescence and image acquisition for each dataset
(treated and untreated controls and knockouts) were performed
simultaneously. n = 3–7 sections; *p#0.05; **p#0.01; ***p#0.001.
Means 6 SEM.
(TIF)




We would like to thank Günther Schütz and Stefan Berger for providing us
with CamKCreERT2 mice. We are grateful to G. Schütz and Rohini
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